AbbVie ( ABBV -0.27%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

Let us look at some biotech stocks, AMGN, CRSP, MRNA, SRPT and VRTX, which are poised to beat on fourth-quarter earnings.

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

It's crunch time for biotech projects started on a bet that the industry would shake off its multiyear malaise.

After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...